Granulomatosis with Polyangiitis Drug Market

Granulomatosis with Polyangiitis Drug Market contains market size and forecasts of Granulomatosis with Polyangiitis Drug in global, including the following market information:
Global Granulomatosis with Polyangiitis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Granulomatosis with Polyangiitis Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Granulomatosis with Polyangiitis Drug companies in 2021 (%)
The global Granulomatosis with Polyangiitis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Benralizumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Granulomatosis with Polyangiitis Drug include Bionovis SA, Bristol-Myers Squibb Company, ChemoCentryx Inc, Coherus BioSciences Inc, Genor BioPharma Co Ltd, GlaxoSmithKline Plc, Iltoo Pharma, Panacea Biotec Ltd and Sandoz International GmbH and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Granulomatosis with Polyangiitis Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Granulomatosis with Polyangiitis Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Granulomatosis with Polyangiitis Drug Market Segment Percentages, by Type, 2021 (%)
Benralizumab
Avacopan
Rituximab Biosimilar
Others
Global Granulomatosis with Polyangiitis Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Granulomatosis with Polyangiitis Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Granulomatosis with Polyangiitis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Granulomatosis with Polyangiitis Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Granulomatosis with Polyangiitis Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Granulomatosis with Polyangiitis Drug revenues share in global market, 2021 (%)
Key companies Granulomatosis with Polyangiitis Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Granulomatosis with Polyangiitis Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bionovis SA
Bristol-Myers Squibb Company
ChemoCentryx Inc
Coherus BioSciences Inc
Genor BioPharma Co Ltd
GlaxoSmithKline Plc
Iltoo Pharma
Panacea Biotec Ltd
Sandoz International GmbH
The International Biotechnology Center (IBC) Generium